A detailed history of Benchmark Investment Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Benchmark Investment Advisors LLC holds 6,079 shares of MRK stock, worth $681,334. This represents 0.55% of its overall portfolio holdings.

Number of Shares
6,079
Previous 4,369 39.14%
Holding current value
$681,334
Previous $576,000 30.56%
% of portfolio
0.55%
Previous 0.46%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$123.8 - $132.96 $211,698 - $227,361
1,710 Added 39.14%
6,079 $752,000
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $94,102 - $109,650
831 Added 23.49%
4,369 $576,000
Q4 2023

May 15, 2024

SELL
$100.18 - $109.02 $775,092 - $843,487
-7,737 Reduced 68.62%
3,538 $385,000
Q4 2023

Feb 13, 2024

BUY
$100.18 - $109.02 $776,194 - $844,686
7,748 Added 219.68%
11,275 $1.23 Million
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $17,501 - $19,436
-170 Reduced 4.6%
3,527 $363,000
Q2 2023

Aug 11, 2023

SELL
$108.61 - $118.38 $22,265 - $24,267
-205 Reduced 5.25%
3,697 $426,000
Q1 2023

May 12, 2023

SELL
$102.94 - $114.86 $36,955 - $41,234
-359 Reduced 8.43%
3,902 $415,000
Q4 2022

Feb 21, 2023

SELL
$87.44 - $112.11 $96,970 - $124,329
-1,109 Reduced 20.65%
4,261 $472,000
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $122,230 - $137,312
-1,446 Reduced 21.21%
5,370 $462,000
Q2 2022

Aug 08, 2022

SELL
$83.49 - $94.64 $235,191 - $266,600
-2,817 Reduced 29.24%
6,816 $621,000
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $135,699 - $152,110
1,846 Added 23.71%
9,633 $790,000
Q4 2021

Feb 16, 2022

BUY
$72.28 - $90.54 $562,844 - $705,034
7,787 New
7,787 $597,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $284B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Benchmark Investment Advisors LLC Portfolio

Follow Benchmark Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benchmark Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Benchmark Investment Advisors LLC with notifications on news.